1995
DOI: 10.1016/0006-8993(95)00614-v
|View full text |Cite
|
Sign up to set email alerts
|

Localization and quantification of the dopamine transporter: comparison of [3H]WIN 35,428 and [125I]RTI-55

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

3
22
0

Year Published

1998
1998
2018
2018

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 46 publications
(25 citation statements)
references
References 43 publications
3
22
0
Order By: Relevance
“…The higher doses of atomoxetine produced longer lasting increases in NE EX and greater increases in DA EX than the low dose. However, atomoxetine did not increase DA EX in the DA and DA transporter-rich areasnucleus accumbens and striatum (Soucy et al 1997;Coulter et al 1995). This report is in agreement with tration of vehicle or atomoxetine at time 0 h is indicated by the arrow.…”
Section: Discussionsupporting
confidence: 86%
See 1 more Smart Citation
“…The higher doses of atomoxetine produced longer lasting increases in NE EX and greater increases in DA EX than the low dose. However, atomoxetine did not increase DA EX in the DA and DA transporter-rich areasnucleus accumbens and striatum (Soucy et al 1997;Coulter et al 1995). This report is in agreement with tration of vehicle or atomoxetine at time 0 h is indicated by the arrow.…”
Section: Discussionsupporting
confidence: 86%
“…Values are the mean Ϯ SEM of the % of pre-drug baseline determined at Ϫ1, Ϫ0.5 and 0 h. Adminis-studies using reboxetine and desipramine that have shown selective NE uptake inhibitors increase DA EX as well as NE EX in PFC, but not in the nucleus accumbens (Tanda et al 1994;Linnèr et al 2001) or striatum (Carboni et al 1990;Di Chiara et al 1992). The transporters for NE are relatively abundant compared with DA transporters in the PFC (Gehlert et al 1993;Soucy et al 1997;Coulter et al 1995;Sesack et al 1998) and it has been determined that DA is taken up non-selectively by NE transporters in the PFC (Carboni et al 1990;Di Chiara et al 1992;Tanda et al 1997;Yamamoto and Novotney 1998) as well as co-released (Devoto et al 2001). The NE transporter has similar affinities for NE and DA (Raiteri et al 1977) and presumably extracellularly-released DA may diffuse transsynaptically to NE transporters (Yamamoto and Novotney 1998).…”
Section: Discussionmentioning
confidence: 99%
“…Although the distribution of DAT in the superficial layers of the anterior cingulate cortex matches the innervation by dopamine axons, the DAT fiber density in the deep layers of the prelimbic and infralimbic cortices underestimates the known distribution of dopamine axons in these areas. These observations are supported by biochemical reports of low DAT protein levels in the medial PFC and by autoradiographic studies describing fewer DAT sites in the deep layers of the prelimbic cortex versus the cingulate cortex or subcortical sites [Scatton et al (1985); Coulter et al (1995); but see Descarries et al (1987)]. These findings suggest that the density of DAT in Figure 7.…”
Section: Methodology and Comparison To Published Findings Light Microsupporting
confidence: 78%
“…To selectively visualize SERT, we incubated the sections with 20 p M [ 125 I]-RTI 55, resulting in minimal NET occupancy [4]in the presence of 200 p M of the selective DAT inhibitor 1-[2-(diphenylmethoxy)ethyl]-4-(3-phenylpropyl)piperazine (GBR 12935, Sigma, St. Louis, Mo., USA) [27]. We incubated the sections for 30 min at 25°C in buffer containing 10 m M sodium phosphate at pH 7.4 followed by incubation in the same buffer containing 20 p M [ 125 I]-RTI 55 in the presence of 200 p M of the DAT inhibitor GBR 12935 for 2 h at 25°C [28, 29]. The nonspecific binding was defined by 10 –5 M paroxetine, in consecutive sections incubated as above.…”
Section: Methodsmentioning
confidence: 99%